EP Patent

EP1371361A1 — Novel suppository form comprising an acid-labile active compound

Assigned to DIETRICH, RANGO · Expires 2003-12-17 · 22y expired

What this patent protects

A new administration form for acid-labile active compounds is described. The administration form is a suppository, in particular for rectal administration.

USPTO Abstract

A new administration form for acid-labile active compounds is described. The administration form is a suppository, in particular for rectal administration.

Drugs covered by this patent

Patent Metadata

Patent number
EP1371361A1
Jurisdiction
EP
Classification
—
Expires
2003-12-17
Drug substance claim
No
Drug product claim
No
Assignee
DIETRICH, RANGO
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.